No Data
No Data
Express News | UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050
Eli Lilly Analyst Ratings
Eli Lilly and Co Options Spot-On: On May 2nd, 90,297 Contracts Were Traded, With 329.36K Open Interest
Novo Nordisk Says Oral Version of Wegovy Accepted for FDA Review
Eli Lilly (NYSE:LLY) Announces Promising Trial Data And Updates 2025 Guidance
Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why. -- Barrons.com
Oh its going : That’s what we need, some Bad Kitty tweets.